FI82696C - Foerfarande foer framstaellning av farmakologiskt vaerdefulla pteridiner. - Google Patents

Foerfarande foer framstaellning av farmakologiskt vaerdefulla pteridiner. Download PDF

Info

Publication number
FI82696C
FI82696C FI854862A FI854862A FI82696C FI 82696 C FI82696 C FI 82696C FI 854862 A FI854862 A FI 854862A FI 854862 A FI854862 A FI 854862A FI 82696 C FI82696 C FI 82696C
Authority
FI
Finland
Prior art keywords
group
phenyl
pteridine
yield
melting point
Prior art date
Application number
FI854862A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI854862A0 (fi
FI854862A7 (fi
FI82696B (fi
Inventor
Berthold Narr
Erich Mueller
Josef Nickl
Armin Heckel
Josef Roch
Rainer Zimmermann
Johannes Weisenberger
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of FI854862A0 publication Critical patent/FI854862A0/fi
Publication of FI854862A7 publication Critical patent/FI854862A7/fi
Publication of FI82696B publication Critical patent/FI82696B/fi
Application granted granted Critical
Publication of FI82696C publication Critical patent/FI82696C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/06Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI854862A 1984-12-12 1985-12-10 Foerfarande foer framstaellning av farmakologiskt vaerdefulla pteridiner. FI82696C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843445298 DE3445298A1 (de) 1984-12-12 1984-12-12 Neue pteridine, verfahren zu ihrer herstellung und deren verwendung als zwischenprodukte oder als arzneimittel
DE3445298 1984-12-12

Publications (4)

Publication Number Publication Date
FI854862A0 FI854862A0 (fi) 1985-12-10
FI854862A7 FI854862A7 (fi) 1986-06-13
FI82696B FI82696B (fi) 1990-12-31
FI82696C true FI82696C (fi) 1991-04-10

Family

ID=6252576

Family Applications (1)

Application Number Title Priority Date Filing Date
FI854862A FI82696C (fi) 1984-12-12 1985-12-10 Foerfarande foer framstaellning av farmakologiskt vaerdefulla pteridiner.

Country Status (15)

Country Link
EP (1) EP0185259A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS61140585A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU576924B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1252783A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3445298A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK161327C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8707238A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI82696C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR852996B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL77294A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO161373C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ214522A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH24451A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT81650B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA859462B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276506B2 (en) 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
CN1543465A (zh) * 2001-06-28 2004-11-03 ��������ҽѧ���޹�˾ 用作选择性细菌dhfr抑制剂的新的杂环化合物及其应用
DE10202468A1 (de) * 2002-01-23 2004-09-30 Faustus Forschungs Cie. Translational Cancer Research Gmbh Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung
DK1658081T3 (da) * 2003-08-29 2008-02-25 4 Aza Ip Nv Immunsuppressive virkninger af pteridinderivater
PT1673092E (pt) * 2003-10-17 2007-11-23 4 Aza Ip Nv ''derivados de pteridina substituídos com heterociclos e sua utilização em terapia''
GB2407089A (en) * 2003-10-17 2005-04-20 4 Aza Bioscience Nv Pteridine derivatives
EP1720542A4 (en) * 2004-03-04 2007-11-28 Neurogen Corp ARYL ALKYLAMINO-SUBSTITUTED CHINAZOLINE ANALOGUE
DE102004057595A1 (de) 2004-11-29 2006-06-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
DE102004057594A1 (de) 2004-11-29 2006-06-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substitueirte Pteridine zur Behandlung von entzündlichen Erkrankungen
DE102004057645A1 (de) 2004-11-29 2006-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
DE102004057618A1 (de) 2004-11-29 2006-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
JP5161102B2 (ja) * 2005-11-22 2013-03-13 クドス ファーマシューティカルズ リミテッド mTOR阻害剤としてのピリドピリミジン、ピラゾピリミジンおよびピリミドピリミジン誘導体
RU2445315C2 (ru) * 2005-11-22 2012-03-20 Кудос Фармасьютиклз Лимитед ПРОИЗВОДНЫЕ ПИРИДО-, ПИРАЗО- И ПИРИМИДО-ПИРИМИДИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ mTOR
JP5440934B2 (ja) 2006-05-24 2014-03-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換プテリジン
WO2008009078A2 (en) 2006-07-20 2008-01-24 Gilead Sciences, Inc. 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
US10144736B2 (en) 2006-07-20 2018-12-04 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
MX2009001946A (es) 2006-08-23 2009-03-05 Kudos Pharm Ltd Derivados de 2-metilmorfolin-pirido-, pirazo- y pirimido- pirimidina como inhibidores de mtor.
EP2303875B1 (en) 2008-06-20 2012-11-28 AstraZeneca AB Compositions with and process for methylmorpholin-subsituted pyrido[2,3-d]pyrimidines
KR102335970B1 (ko) 2015-03-04 2021-12-07 길리애드 사이언시즈, 인코포레이티드 톨 유사 수용체 조정제 화합물
US10370342B2 (en) 2016-09-02 2019-08-06 Gilead Sciences, Inc. Toll like receptor modulator compounds
ES2826748T3 (es) 2016-09-02 2021-05-19 Gilead Sciences Inc Derivados de 4,6-diamino-pirido[3,2-d]pirimidina como moduladores de receptores de tipo Toll
TWI751517B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202210480A (zh) 2019-04-17 2022-03-16 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI879779B (zh) 2019-06-28 2025-04-11 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3159628A (en) * 1962-05-28 1964-12-01 Smith Kline French Lab Pteridine-5-oxide derivatives
DE3323932A1 (de) * 1983-07-02 1985-01-10 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 2-piperazino-pteridine, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel

Also Published As

Publication number Publication date
AU5123285A (en) 1986-06-19
DK572685A (da) 1986-06-13
CA1252783A (en) 1989-04-18
PT81650B (pt) 1988-04-21
PH24451A (en) 1990-06-25
ZA859462B (en) 1987-07-29
FI854862A0 (fi) 1985-12-10
DE3445298A1 (de) 1986-06-12
PT81650A (de) 1986-01-01
NO161373C (no) 1989-08-09
EP0185259A3 (de) 1989-03-01
NO854965L (no) 1986-06-13
GR852996B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1986-04-16
ES8707238A1 (es) 1987-07-16
FI854862A7 (fi) 1986-06-13
FI82696B (fi) 1990-12-31
DK161327C (da) 1991-12-09
JPS61140585A (ja) 1986-06-27
DK572685D0 (da) 1985-12-11
DK161327B (da) 1991-06-24
ES549806A0 (es) 1987-07-16
EP0185259A2 (de) 1986-06-25
AU576924B2 (en) 1988-09-08
IL77294A (en) 1989-02-28
NO161373B (no) 1989-05-02
NZ214522A (en) 1988-07-28

Similar Documents

Publication Publication Date Title
FI82696C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla pteridiner.
FI80454C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 2-piperazino-pteridiner.
HU183087B (en) Process for producing substituted pyrano- and thiopyrano-quinolines
SU999972A3 (ru) Способ получени производных пиридо-(1,2-а) пиримидина или их фармацевтически приемлемых солей,или их оптически активных изомеров
NO152373B (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 8-fenyl-purin-derivater
KR900005836B1 (ko) 1,2,4-트리아조로[4,3-c]피리미딘
US4560685A (en) 2-Piperazino-pteridines useful as antithrombotics and antimetastatics
Abdel-Rahman et al. SYNTHESIS OF SOME NEW THIENO [2, 3-b] PYRIDINES, PYRIDO [3′, 2′: 4, 5]-THIENO [3, 2-d] PYRIMIDINES AND PYRIDO [3′, 2′: 4, 5] THIENO [3, 2-d][1, 2, 3]-TRIAZINES
FI61029B (fi) Nytt foerfarande foer framstaellning av terapeutiskt anvaendbara dibenso(b,e)(1,4)diazepiner
US3764598A (en) Pyrimidopyridazine derivatives
FI67220C (fi) Foerfarande foer framstaellning av antitrombotiskt verkande 2-perhydro-1,4-diazino)-pyrimido(5,4-d)pyrimidiner
Revanasiddappa et al. Synthesis and biological studies of some novel schiff bases and hydrazones derived from 8-hydroxy quinoline moiety
LeMahieu et al. Synthesis and antiallergy activity of 5-oxo-5H-thiazolo [2, 3-b] quinazolinecarboxylic acids
Janin et al. A formal new access to the benzo [c] phenanthridine alkaloids, synthesis of nitidine and o-methyl fagaronine analogues.
KR920000271B1 (ko) 1,2,4-트리아조로[1,5-c] 피리미딘 및 이의 제조방법
US3467657A (en) As-triazino(5,6-b)indoles
US20040072856A1 (en) 4-ANILINO[2,3-b]QUINOLINE DERIVATIVES,THEIR PREPARATION PROCECC ANDPHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
Carbon et al. Adjacent Nitro and Guanidino Groups. III. Preparation and Rearrangement of Some Pyrido [2, 3-e]-as-triazine 1-Oxides1
FI74467C (fi) Foerfarande foer framstaellning av 1,2,3,10-tetrahydro-10-oxo-cyklopenta/d/pyrido/1,2-a/pyrimidin- och 1,2,3,4-tetrahydro-11-oxo-11h-pyrido/2,1-b/kinazolinderivat.
Hassan et al. Nucleophilic reactions of 1-substituted-2, 5-dithiobiureas with chlorinated benzo-and naphthoquinones as well as (1, 3-dioxo-2, 3-dihydro-1 (H)-inden-2-ylidene) propanedinitrile
DeCroix et al. Pteridines from. alpha.-phenyl-N, N-dimethylacetamidine
Temple Jr et al. Methylation and amination of folic acid
KR101178495B1 (ko) 3,6-이치환-4,5,6,7-테트라하이드로-1H-피라졸로[3,4-c]피리딘-7-온 화합물과 이 화합물의 제조방법
IE920704A1 (en) Nitrogen oxides of aza- and diaza-anthracenedione¹derivatives as antitumor agents
KR850000321B1 (ko) 2-(퍼하이드로-1,4-디아지노)-피리미도[5,4-d] 피리미딘의 제조방법

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: DR. KARL THOMAE GESELLSCHAFT MIT